Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Redermo Wound Matrix

K-Number: K260020 · 2026-04-16

Decision Date2026-04-16
Product CodeQSZ
DecisionSubstantially Equivalent

Device Summary

Redermo Wound Matrix is a medical device manufactured by Beijing Kreate Medical Co., Ltd.. It received FDA 510(k) clearance on 2026-04-16 under approval number K260020. The device is classified under product code QSZ. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Redermo Wound Matrix?

Redermo Wound Matrix is a medical device that received FDA 510(k) clearance on 2026-04-16. It is manufactured by Beijing Kreate Medical Co., Ltd.. The 510(k) number is K260020.

When was Redermo Wound Matrix approved by the FDA?

Redermo Wound Matrix received FDA 510(k) clearance on 2026-04-16, under approval number K260020.

What company makes Redermo Wound Matrix?

Redermo Wound Matrix is manufactured by Beijing Kreate Medical Co., Ltd..

What is the FDA product code for Redermo Wound Matrix?

The FDA product code for Redermo Wound Matrix is QSZ.

Related Clinical Trials

Other Devices by Beijing Kreate Medical Co., Ltd.

Related Devices (Code: QSZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.